Swiss Life Asset Management Ltd Reduces Stock Holdings in Avantor, Inc. $AVTR

Swiss Life Asset Management Ltd lowered its holdings in Avantor, Inc. (NYSE:AVTR) by 69.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 32,023 shares of the company’s stock after selling 73,997 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Avantor were worth $400,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the business. EverSource Wealth Advisors LLC lifted its position in Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after purchasing an additional 1,189 shares during the period. Strategic Wealth Investment Group LLC acquired a new stake in Avantor during the 2nd quarter worth about $32,000. Osaic Holdings Inc. grew its position in Avantor by 60.9% during the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after purchasing an additional 1,064 shares during the period. Farther Finance Advisors LLC raised its stake in shares of Avantor by 172.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 3,709 shares of the company’s stock valued at $46,000 after buying an additional 2,346 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Avantor by 28.1% during the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after buying an additional 905 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Insider Activity

In other Avantor news, Director Sanjeev K. Mehra bought 125,000 shares of Avantor stock in a transaction dated Tuesday, March 10th. The stock was acquired at an average cost of $8.01 per share, with a total value of $1,001,250.00. Following the purchase, the director directly owned 475,000 shares in the company, valued at $3,804,750. This represents a 35.71% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Gregory L. Summe bought 100,000 shares of the firm’s stock in a transaction dated Thursday, February 12th. The shares were acquired at an average price of $9.40 per share, for a total transaction of $940,000.00. Following the transaction, the director directly owned 400,000 shares in the company, valued at approximately $3,760,000. This represents a 33.33% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 275,000 shares of company stock worth $2,399,250 over the last three months. 1.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

AVTR has been the topic of a number of recent research reports. Bank of America downgraded Avantor from a “buy” rating to a “neutral” rating and set a $13.00 target price on the stock. in a research note on Monday, December 15th. Morgan Stanley set a $10.00 price target on Avantor in a report on Friday, February 13th. UBS Group restated a “neutral” rating and issued a $10.50 price objective on shares of Avantor in a research report on Thursday, February 12th. Barclays reaffirmed an “underweight” rating and set a $8.50 price objective on shares of Avantor in a research note on Friday, March 6th. Finally, Wells Fargo & Company cut their target price on shares of Avantor from $16.00 to $14.00 and set an “overweight” rating for the company in a report on Friday, February 13th. Three analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $11.80.

Avantor Price Performance

NYSE:AVTR opened at $7.68 on Thursday. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. Avantor, Inc. has a 52 week low of $7.38 and a 52 week high of $16.44. The stock’s 50-day moving average price is $9.63 and its 200-day moving average price is $11.36. The stock has a market capitalization of $5.23 billion, a PE ratio of -9.84, a price-to-earnings-growth ratio of 3.03 and a beta of 0.97.

Avantor (NYSE:AVTR) last released its quarterly earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.21 by $0.01. The company had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Avantor had a positive return on equity of 10.45% and a negative net margin of 8.09%.Avantor’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.27 EPS. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. As a group, equities analysts expect that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.